Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,171 total articles

Clover Health CEO Jamie Reynoso Executes RSU-Related Stock Sale Amid Regulatory and Financial Developments

Clover Health CEO Jamie Reynoso Executes RSU-Related Stock Sale Amid Regulatory and Financial Developments

Jamie L. Reynoso, Chief Executive Officer of Clover Health Investments Corp. (NASDAQ: CLOV), completed the sale of 6,350 shares of the company's Class A Common Stock on June 15, 2026. The transaction, valued at $29,273, was executed to fulfill mandatory tax withholding requirements tied to the vesting of restricted stock units (RSUs). This sale fol…

ATN International Insider Activity: Cornelius B. Prior Jr. Executes $2.28M Stock Sale Amid Strategic Shifts

ATN International Insider Activity: Cornelius B. Prior Jr. Executes $2.28M Stock Sale Amid Strategic Shifts

Cornelius B. Prior Jr., a ten percent owner of ATN International, Inc. (NASDAQ: ATNI), has reported the sale of $2,279,030 worth of company common stock. The transactions, executed indirectly through VI E-Cell TropicalTelecom Ltd., a U.S. Virgin Islands limited company where Mr. Prior Jr. serves as chairman and holds an 80% ownership stake, occurre…

Chegg CEO Daniel Rosensweig's Shares Withheld for Tax Obligations

Chegg CEO Daniel Rosensweig's Shares Withheld for Tax Obligations

Daniel Rosensweig, President, CEO, and Executive Chairman of CHEGG, INC (NASDAQ:CHGG), had 8,293 shares of the company’s common stock automatically withheld on June 12, 2026, to satisfy federal and state tax obligations. The disposition was not a sale but a direct cancellation by the company following the vesting and settlement of performance stock…

Ligand Pharmaceuticals Director Jason Haas Offloads $1.65 Million in Shares Amid Earnings Miss and Merger Restructuring

Ligand Pharmaceuticals Director Jason Haas Offloads $1.65 Million in Shares Amid Earnings Miss and Merger Restructuring

Jason Haas, a director at Ligand Pharmaceuticals Inc. (NASDAQ: LGND), executed a significant stock sale on June 12, 2026, divesting approximately $1.65 million in common stock through the exercise of stock options. The transaction occurs as the company's shares hover near their 52-week peak, despite recent financial results that fell short of marke…

Viant Technology COO Christopher Vanderhook Executes $101,287 Share Sale Amid Recent Market Volatility

Viant Technology COO Christopher Vanderhook Executes $101,287 Share Sale Amid Recent Market Volatility

Viant Technology Inc. (NASDAQ:DSP) Chief Operating Officer Christopher Vanderhook executed a sale of 9,125 shares on June 15, 2026, generating proceeds of $101,287. The transaction was structured to cover estimated tax obligations arising from the vesting and settlement of restricted stock units. At the time of execution, the shares were valued at …